Replies to post #319126 on NorthWest Biotherapeutics Inc (NWBO)

[Veritas]

anders, and/or anyone else,

Let's say that TLD is solid, but not spectacular...

(1) what are the chances that the FDA does not approve
(2) what would happen to the share price if the FDA does not approve, even if trial data shows that efficacy for the treatment is solid?
(3) what are the chances that FDA does NOT approve, but it is approved elsewhere in Europe?

Any broad-brush conjecture would be appreciated.